Ohm, Right you where !!! :) it seems that you
Post# of 154848
(Total Views: 547)
Posted On: 03/29/2020 5:11:43 PM
Ohm,
Right you where !!!
it seems that you are ahead of most of us.
This begs the question of the use of Leronlimab with (for) Pneumonia.
I am not implying that we can treat microbial, bacterial and/or fungal pneumonia with Leronlimab, however, often the cause of death, as you where discussing, is complications with the immune system of the patients.
Congestive heart failure, is a case at hand, pneumonia weakens the immune system and either aggravates an underlying condition or causes the hart to fail. This is the way most pass away.
Apparently COVID is playing the same partiture in several cases and, if it can help at all by supporting (and muting) the immune response it will be very useful. Same can be said for Pneumonia.
Right you where !!!
it seems that you are ahead of most of us. This begs the question of the use of Leronlimab with (for) Pneumonia.
Quote:
Pneumonia is the world’s leading cause of death among children under 5 years of age, accounting for 16% of all deaths of children under 5 years old killing approximately 2,400 children a day in 2015. There are 120 million episodes of pneumonia per year in children under 5, over 10% of which (14 million) progress to severe episodes. There was an estimated 880,000 deaths from pneumonia in children under the age of five in 2016. Most were less than 2 years of age.
Quote:
For US adults, pneumonia is the most common cause of hospital admissions other than women giving birth. About 1 million adults in the US seek care in a hospital due to pneumonia every year, and 50,000 die from this disease.
Quote:.
Older people have higher risk of getting pneumonia, and are more likely to die from it if they do. For US seniors, hospitalization for pneumonia has a greater risk of death compared to any of the other top 10 reasons for hospitalization
Quote:
Pneumonia is a huge burden on our healthcare systems. In the US, pneumonia was one of the top ten most expensive conditions seen during inpatient hospitalizations. In 2013, pneumonia had an aggregate cost of nearly $9.5 billion for 960,000 hospital stays.
Quote:
The death rate from pneumonia in the US has had little improvement since antibiotics became widespread more than half a century ago. We are not yet winning the battle against pneumonia.
I am not implying that we can treat microbial, bacterial and/or fungal pneumonia with Leronlimab, however, often the cause of death, as you where discussing, is complications with the immune system of the patients.
Congestive heart failure, is a case at hand, pneumonia weakens the immune system and either aggravates an underlying condition or causes the hart to fail. This is the way most pass away.
Apparently COVID is playing the same partiture in several cases and, if it can help at all by supporting (and muting) the immune response it will be very useful. Same can be said for Pneumonia.
(3)
(0)